A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone

Wang, K; Wang, C; Xi, L; Zhang, Y; Ouyang, Y; Lou, H; Zhang, W; Zhang, L

HERO ID

2232558

Reference Type

Journal Article

Year

2014

Language

English

PMID

24248037

HERO ID 2232558
In Press No
Year 2014
Title A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone
Authors Wang, K; Wang, C; Xi, L; Zhang, Y; Ouyang, Y; Lou, H; Zhang, W; Zhang, L
Journal International Archives of Allergy and Immunology
Volume 163
Issue 1
Page Numbers 51-58
Abstract <strong>BACKGROUND: </strong>Short message service (SMS) has been suggested as an effective method to improve adherence to medical therapy in some chronic diseases. However, data on the effects of SMS interventions to allergic rhinitis (AR) treatment is limited at present. We aimed to assess whether a daily SMS reminder could improve AR patients' adherence to medication and treatment outcomes.<br /><br /><strong>METHODS: </strong>Fifty outpatients with AR were randomized to either receive (SMS group) or not (control group) a daily SMS reminder on their cell phone to take intranasal corticosteroid treatment for 30 days. The primary study outcomes were self-reported adherence to medication, clinic attendance rate, and severity of AR symptoms using a visual analogue scale (VAS). Secondary outcomes were changes in nasal patency (minimum cross-sectional area, nasal cavity volume, and nasal airway resistance) and exhaled nasal nitric oxide levels.<br /><br /><strong>RESULTS: </strong>Self-reported adherence to medication in the SMS group (15/25, 60%), was significantly higher than in the control group (7/25, 28%, p = 0.02). Similarly, the clinic attendance rate in the SMS group (72%) was significantly higher than in the control group (40%, p = 0.02). Although the VAS score improved significantly from baseline in both study groups, the improvement in the SMS group was significantly greater than in the control group (4.38 ± 4.38 vs. 8.74 ± 6.54, p = 0.031). No significant differences were observed between the two groups for the secondary outcomes.<br /><br /><strong>CONCLUSIONS: </strong>A daily SMS reminder may be an effective intervention to improve adherence to medication and treatment outcomes in AR patients.
Doi 10.1159/000356317
Pmid 24248037
Wosid WOS:000329603200010
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English
Keyword Allergic rhinitis; Treatment; Adherence; Short message service